Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease

Neurobiology of Disease

Volumn 11, Issue 1, 2002, Pages 106-110

  Bonelli, Raphael M ^a   Aschoff, Andreas ^b   Niederwieser, Gerald ^a   Heuberger, Clemens ^c   Jirikowski, Gustaf ^b  

^a Hospital BHB Eggenberg   (Austria)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Alzheimer's disease; Apoptosis; Tau protein; Tissue transglutaminase; Vascular dementia

Indexed keywords

BIOCHEMICAL MARKER; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TAU PROTEIN;

ADULT; AGE; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CEREBROSPINAL FLUID EXAMINATION; CEREBROSPINAL FLUID LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEGENERATION; DEMENTIA; DIAGNOSTIC PROCEDURE; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PROBABILITY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

EID: 0036453620     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0535     Document Type: Article

References (38)

1. Anderson, A. J., Su, J. H., & Cotman, C. W. (1996) DNA damage and apoptosis in Alzheimer's disease: Colocalization with c- Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16, 1710-1719.
2. Ando, M., Kunii, S., Tatematsu, T., & Nagata, Y. (1993) Rapid and transient alterations in transglutaminase activity in rat superior cervical ganglia following denervation or axotomy. Neurosci. Res. 17, 47-52.
3. Andreasen, N., Minthon, L., Davidsson, P., Vanmechelen, E., Vanderstichele, H., & Winblad, B., et al. (2001) Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch. Neurol. 58, 373-379.
4. Chun, W., Lesort, M., Tucholski, J., Faber, P. W., MacDonald, M. E., & Ross, C. A., et al. (2001a) Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells. Neurobiol. Dis. 8, 391-404.
5. Chun, W., Lesort, M., Tucholski, J., Ross, C. A., & Johnson, G. V. (2001b) Tissue transglutaminase does not contribute to the formation of mutant huntingtin aggregates. J. Cell. Biol. 153, 25-34.
6. Citron, B. A., SantaCruz, K. S., Davies, P. J., & Festoff, B. W. (2000) Intronexon swapping of transglutaminase mRNA and neuronal tau aggregation in Alzheimer's disease. J. Biol. Chem. 29, 29.
7. Cotman, C. W., & Anderson, A. J. (1995) A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10, 19-45.
8. Delacourte, A., & Defossez, A. (1986) Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J. Neurol. Sci. 76, 173-186.
9. Dudek, S. M., & Johnson, G. V. (1993) Transglutaminase catalyzes the formation of sodium dodecyl sulfate- insoluble, Alz-50-reactive polymers of tau. J. Neurochem. 61, 1159-1162.
10. El Alaoui, S., Mian, S., Lawry, J., Quash, G., & Griffin, M. (1992) Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis). FEBS Lett. 311, 174-178.
11. Facchiano, F., Benfenati, F., Valtorta, F., & Luini, A. (1993) Covalent modification of synapsin 1 by a tetanus toxin-activated transglutaminase. J. Biol. Chem. 268, 4588-4591.
12. Festoff, B. W., Suo, Z., & Citron, B. A. (2001) Plasticity and stabilization of neuromuscular and CNS synapses: Interactions between thrombin protease signaling pathways and tissue transglutaminase. Int. Rev. Cytol. 211, 153-77.
13. Fesus, L., Thomazy, V., & Falus, A. (1987) Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224, 104-108.
14. Folk, J. E., & Finlayson, J. S. (1979) The epsilon-(gamma-glutamyl)-lysine crosslink and the catalytic role of transglutaminases. Adv. Protein Chem. 31, 1-133.
15. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
16. Friedrich, P., Fesus, L., Tarcsa, E., & Czeh, G. (1991) Protein cross-linking by transglutaminase induced in long-term potentiation in the Cal region of hippocampal slices. Neuroscience 43, 331-334.
17. Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168.
18. Grierson, A. J., Johnson, G. V., & Miller, C. C. (2001) Three different human tau isoforms and rat neurofilament light, middle and heavy chain proteins are cellular substrates for transglutaminase. Neurosci. Lett. 298, 9-12.
19. Hachinski, V. C., Hiff, L. D., Zilhka, E., Du Boulay, G., H., McAllister, V. L., & Marshall, J., et al. (1975) Cerebral blood flow in dementia. Arch. Neurol. 32, 632-637.
20. Jellinger, K., Danielczyk, W., Fischer, P., & Gabriel, E. (1990) Clinicopathological analysis of dementia disorders in the elderly. J. Neurol. Sci. 95, 239-258.
21. Johnson, G. V., Cox, T. M., Lockhart, J. P., Zinnerman, M. D., Miller, M. L., & Powers, R. E. (1997) Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res. 751, 323-329.
22. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., & Grzeschik, K. H., et al. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
23. Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA 83, 4044-4048.
24. Lee, V. M., Balin, B. J., Orivos, L., Jr., & Trojanowski, J. Q. (1991) A68: A major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251, 675-678.
25. Lesort, M., Tucholski, J., Miller, M. L., & Johnson, G. V. (2000) Tissue transglutaminase: A possible role in neurodegenerative diseases. Prog. Neurobiol. 61, 439-463.
26. Letenneur, L., Launer, L. J., Andersen, K., Dewey, M. E., Ott, A., & Copeland, J. R., et al. (2000) Education and the risk for Alzheimer's disease: Sex makes a difference. EURODEM pooled analyses. EURODEM Incidence Research Group. Am. J. Epidemiol. 151, 1064-1071.
27. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
28. Mattson, M. P. (1992) Calcium as sculptor and destroyer of neural circuitry. Exp. Gerontol. 27, 29-49.
29. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
30. Miller, M. L., & Johnson, G. V. (1995) Transglutaminase cross-linking of the tau protein. J. Neurochem. 65, 1760-1770.
31. Norlund, M. A., Lee, J. M., Zainelli, G. M., & Muma, N. A. (1999) Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease. Brain Res. 851, 154-163.
32. Ohashi, H., Itoh, Y., Birckbichler, P. J., & Takeuchi, Y. (1995) Purification and characterization of rat brain transglutaminase. J. Biochem. (Tokyo) 118, 1271-1278.
33. Oliverio, S., Amendola, A., Rodolfo, C., Spinedi, A., & Piacentini, M. (1999) Inhibition of "tissue" transglutaminase increases cell survival by preventing apoptosis. J. Biol. Chem. 274, 34123-34128.
34. Roman, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., & Garcia, J. H., et al. (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
35. Tapiola, T., Pirttila, T., Mehta, P. D., Alafuzofff, I., Lehtovirta, M., & Soininen, H. (2000a) Relationship between apoE genotype and CSF beta-amyloid (l-42) and tau in patients with probable and definite Alzheimer's disease. Neurobiol. Aging 21, 735-740.
36. Tapiola, T., Pirttila, T., Mikkonen, M., Mehta, P. D., Alafuzoff, I., & Koivisto, K., et al. (2000b) Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease. Neurosci. Lett. 280, 119-122.
37. Tucholski, J., Lesort, M., & Johnson, G. V. (2001) Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience 102, 481-491.
38. Zemaitaitis, M. O., Lee, J. M., Troncoso, J. C., & Muma, N. A. (2000) Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol. 59, 983-989.